Literature DB >> 1283863

Evaluation of surgical risk in palliation and resection of pancreatic cancer. Perspective study and tables to calculate the risk.

S Pedrazzoli1, B Bonadimani, C Sperti, C Pasquali, F Cappellazzo, S Catalini, A Piccoli, C Militello.   

Abstract

High morbidity and mortality rates are reported for bypass and resective surgery of pancreatic cancer. In a retrospective study we correctly predicted the postoperative course in 88% of the patients who underwent bypass surgery and 83% of those who had a resection for pancreatic cancer. Before starting with clinical application of this scoring system, we undertook a prospective study to confirm its predictive value. Sixty-seven consecutive patients with pancreatic cancer were included: 42 patients underwent bypass surgery and 25 pancreatic resections. The operative mortality was 14% for palliative surgery and 0% for resective surgery. Surgical team and nurses were totally unaware of the predicted risk. The preoperative forecast proved to be correct in 81% of bypass surgery and in 88% of resective surgery, although surgical mortality had decreased from 21 to 14% for bypass surgery and from 17 to 0% for resective surgery. Tables are included to calculate the surgical risk for each of 162 combinations of the risk factors considered in the predictive model (81 for bypass surgery and 81 for resective surgery). Calculation of surgical risk is important when evaluating different treatments for pancreatic cancer are available.

Entities:  

Mesh:

Year:  1992        PMID: 1283863     DOI: 10.1007/bf02924360

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  28 in total

1.  Self-expanding stainless steel biliary stents.

Authors:  H G Coons
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

2.  Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response variables.

Authors:  N V Christou; J Tellado-Rodriguez; L Chartrand; B Giannas; B Kapadia; J Meakins; H Rode; J Gordon
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

3.  Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas.

Authors:  A S Hermreck; C Y Thomas; S R Friesen
Journal:  Am J Surg       Date:  1974-06       Impact factor: 2.565

4.  Resectional surgical procedures for carcinoma of the head of the pancreas.

Authors:  N J Lygidakis; M N van der Hyde; H J Houthoff; M E Schipper; K Huibregtse; G N Tytgat; M J Lubber; J W Reeders; M M Bosey; J Oosting
Journal:  Surg Gynecol Obstet       Date:  1989-02

5.  Total pancreatectomy for ductal adenocarcinoma of the pancreas: an update.

Authors:  J A van Heerden; D C McIlrath; D M Ilstrup; L H Weiland
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

6.  Preoperative nutritional assessment to predict postoperative complication in gastric cancer patients.

Authors:  H Yamanaka; M Nishi; T Kanemaki; N Hosoda; K Hioki; M Yamamoto
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 May-Jun       Impact factor: 4.016

7.  Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan.

Authors:  A Nakase; Y Matsumoto; K Uchida; I Honjo
Journal:  Ann Surg       Date:  1977-01       Impact factor: 12.969

8.  Percutaneous transhepatic drainage of the biliary tract: technique and results in 104 cases.

Authors:  T Nakayama; A Ikeda; K Okuda
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

9.  Decreased morbidity and mortality after pancreatoduodenectomy.

Authors:  P A Grace; H A Pitt; R K Tompkins; L DenBesten; W P Longmire
Journal:  Am J Surg       Date:  1986-01       Impact factor: 2.565

10.  Surgical management of unresectable carcinoma of the pancreas.

Authors:  M G Sarr; J L Cameron
Journal:  Surgery       Date:  1982-02       Impact factor: 3.982

View more
  1 in total

1.  Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer.

Authors:  G V Raikar; M M Melin; A Ress; S Z Lettieri; J J Poterucha; D M Nagorney; J H Donohue
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.